Fulgent Genetics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $85,389 | $71,138 | $83,336 | $84,069 |
Gross Profit | 25,679 | 21,490 | 32,582 | 35,512 |
EBITDA | -21,955 | -19,961 | -23,028 | -77 |
EBIT | -29,631 | -25,961 | -29,140 | -6,115 |
Net Income | -29,530 | -24,826 | -23,418 | -6,608 |
Net Change In Cash | 85,389 | 71,138 | 83,336 | 84,069 |
Free Cash Flow | -27,616 | 1,895 | -83,123 | 5,057 |
Cash | 26,305 | 23,399 | 50,193 | 117,641 |
Basic Shares | 28,005 | 30,881 | 30,777 | 30,749 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $322,671 | $283,470 | $289,213 | $618,968 |
Gross Profit | 130,875 | 107,215 | 104,456 | 366,901 |
EBITDA | -45,827 | -26,858 | -147,454 | 217,700 |
EBIT | -69,950 | -51,786 | -173,597 | 185,038 |
Net Income | -60,513 | -42,708 | -167,825 | 143,403 |
Net Change In Cash | 322,671 | 283,470 | 289,213 | 618,968 |
Free Cash Flow | -124,212 | -19,255 | 4,796 | 234,745 |
Cash | 50,193 | 55,144 | 97,473 | 79,506 |
Basic Shares | 30,777 | 30,235 | 29,784 | 30,964 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.88 |
2026-03-31 | -$0.36 |
2025-12-31 | $0.16 |
2025-09-30 | $0.14 |